EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy

Bevin Neill, Adriana Retamales Romero, Owen S Fenton iD

ACS Applied Bio Materials · 19.08.2024 · 7 (8) · 4894-4913

DOI: 10.1021/acsabm.3c00721 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Applied Bio Materials, online erschienen am 06.11.2023. Verfasst von Bevin Neill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, N…. Hauptthemen laut MEDLINE: Melanoma, Cancer Vaccines, RNA, Messenger. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIBIB NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) vaccines are promising platforms for cancer immunotherapy because of their potential to encode for a variety of tumor antigens, high tolerability, and capacity to induce strong antitumor immune responses. However, the clinical translation of mRNA cancer vaccines can be hindered by the inefficient delivery of mRNA in vivo. In this review, we provide an overview of mRNA cancer vaccines by discussing their utility in treating melanoma. Specifically, we begin our review by describing the barriers that can impede mRNA delivery to target cells. We then review native mRNA structure and discuss various modification methods shown to enhance mRNA stability and transfection. Next, we outline the advantages and challenges of three nonviral carrier platforms (lipid nanoparticles, polymeric nanoparticles, and lipopolyplexes) frequently used for mRNA delivery. Last, we summarize preclinical and clinical studies that have investigated nonviral mRNA vaccines for the treatment of melanoma. In writing this review, we aim to highlight innovative nonviral strategies designed to address mRNA delivery challenges while emphasizing the exciting potential of mRNA vaccines as next-generation therapies for the treatment of cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCancer VaccinesRNA, MessengerHumansAnimalsBiocompatible MaterialsNanoparticlesMaterials TestingImmunotherapyParticle Size

Stichwörter der Autor:innen

lipid nanoparticleslipopolyplexesmRNA vaccinesmelanomapolymeric nanoparticles

Substanzen

Cancer VaccinesRNA, MessengerBiocompatible Materials

Autor:innen und Institutionen

  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Owen S Fenton

Förderung

  • NCATS NIH HHS
  • NIBIB NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Neill, B., Romero, A. R., & Fenton, O. S. (2024). Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy. ACS Applied Bio Materials, 7(8), 4894-4913. https://doi.org/10.1021/acsabm.3c00721

Vancouver

Neill B, Romero AR, Fenton OS. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy. ACS Applied Bio Materials. 2024;7(8):4894-4913. doi:10.1021/acsabm.3c00721

BibTeX
@article{Neill2024,
  author = {Neill, Bevin and Romero, Adriana Retamales and Fenton, Owen S},
  title = {Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  volume = {7},
  number = {8},
  pages = {4894--4913},
  doi = {10.1021/acsabm.3c00721}
}
Kostenlos starten →